Risks with da Vinci Surgical Robot May Outweigh Benefits in Many Uses
A recent review suggests that there may be no scientific justification for the use of the da Vinci surgical robot in many of the most common uses, and warns that the manufacturer may face substantial liability for injuries that occurred when users suffered burns, tears and other complications following robotic surgery.
A report by Citron Research concludes that there is no benefit to using the da Vinci Surgical System in gynecological or prostate surgeries. The report was issued last week for investors, warning that the stock price for the manufacturer, Intuitive Surgical, is likely to drop to half of its current value this year due to legal troubles and problems with its sole product.
The report followed a position statement by the American Institute of Gynecologic Laparascoptists, which found that outcomes between traditional vaginal hysterectomies and those conducted with the da Vinci were about the same. However, the da Vinci costs significantly more, and Citron argues that it opens patients up to the risk of perforated, torn and burned internal organs. Using the da Vinci also takes longer and exposes the patient to more anaesthesia, Cintron reports.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.
Learn MoreThe report notes that prostate surgery, another major use of the da Vinci, is also a problem area. The report determines that da Vinci prostatectomies add approximately $4,800 in medical costs to each surgery and there is no scientific evidence that it has produced better outcomes.
“It is astonishing that after being in the marketplace for 10 years, Intuitive finds itself with its only product having no scientific justification for widespread use in the 70%+ of its most common applications: Prostatectomies, and gynecological procedures such as hysterectomy and fibroid surgery,” the report states. “Citron can think of no other correlate in the medical field in the last generation.”
Da Vinci Lawsuits Likely to Hit Intuitive Hard: Report
The report warns that the findings of the report and an increasing number of adverse event reports detailing da Vinci surgical errors, complications and deaths, will lead to increased legal liability for the company in the future.
The da Vinci Surgical System was approved by the FDA in 2000 for use in urologic, laparoscopic, gynecologic and non-cardiovascular thoracoscopic surgical procedures and thoracoscopically assisted cardiotomy procedures.
The surgical robot has four arms, three for holding surgical instruments including scalpels and electrocautery instruments, and a fourth with an endoscopic camera. It is controlled by a surgeon looking through an imaging device at a 3-D image of the surgical area. The surgeon controls the robot with foot pedals and hand controllers.
Intuitive Surgical faces an increasing number of da Vinci surgical robot lawsuits brought in courts throughout the country on behalf of patients who claim that they were not warned about the risk of punctured organs, electrical burns and other complications. Many of these problems have been blamed on inexperienced surgeons who feel pressured to use the da Vinci robot as often as possible due to the machine’s high cost to the hospital.
Citron warns that juries will look harshly on Intuitive’s aggressive marketing schemes, particularly when they are introduced to data from numerous studies and reports showing that the device may have been overhyped and understudied before being put on the market.
2 Comments
"*" indicates required fields
AndrewFebruary 9, 2016 at 5:57 pm
While it may not have a specific benefit for gynecological or prostate surgeries, I’ve experienced a number of excellent applications for the da Vinci surgical robot for urological surgery in PA. It’s reduced the average recovery times for patients, and is often slightly faster than conducting the surgery through traditional methods.
Avi Deshmukh, MD, FACS, MBA, MHAMarch 17, 2013 at 10:42 pm
It is very true that the surgical art best be expression of human hands, and not an extraneous instrument to facilitate the human performance. Robotics is a marketing tool rather than furthering human capabilities. The patient must know the established benefits of robot use rather than "cool" hype. Now the clinical studies are coming forward questioning the real short term , long term, and financi[Show More]It is very true that the surgical art best be expression of human hands, and not an extraneous instrument to facilitate the human performance. Robotics is a marketing tool rather than furthering human capabilities. The patient must know the established benefits of robot use rather than "cool" hype. Now the clinical studies are coming forward questioning the real short term , long term, and financial benefits to the consumers of the robotic use, and the facts do not support extensive use of robots for very common surgical procedures that a good surgeon can perform with even better results without robot. Robots are expensive tools that were able to FOOL FDA into generation of Hyped technology that has corroded the economics of healthcare system. Prudent doctors, hospitals, and insurers need to peek into the real facts of robotic surgery rather than fall a prey to Marketing Strategy of the manufacturer, that states and dictates that if you do not use robot for surgery, then you are doomed to lose your market share. Hopefully, when consumers have to pay for robot use, and they realize the truth, they will define the future of robotic surgey hype, and yes, the insurers will join this growing mountain of rising costs of healthcare, as a result of a savvy marketing strategy. It will be better to face facts earlier rather than later.